Covalon Technologies Ltd. (“the Company”) is incorporated under the laws of Ontario and is engaged in the business of developing, licensing, and selling medical technologies. The Company has received regulatory approval on numerous products and is currently generating revenue. The Company has adopted a business model that contracts the manufacturing and distribution of its commercialized products through partners. The Company generates its revenues through development contracts, licensing agreements, and distribution contracts and sales. The Company is listed on the TSX Venture Exchange, having the symbol COV.
Stock Quote
TSXV :  COV.V (Common Stock)
 + 0.01 (0.16%)
Stock chart for: COV.V.  Currently trading at Can$6.09 with a 52 week high of Can$8.00 and a 52 week low of Can$2.02.
Data as of May 25, 2018 2:53 p.m. ET
Minimum 15 minute delay
Refresh quote
Recent NewsMore »
Upcoming EventsMore »
June 24, 2018 through June 27, 2018
2018 Oley Consumer/Clinician Conference
August 13, 2018
Q3 2018 Covalon Technologies Ltd. Earnings Release
Data provided by Nasdaq. Minimum 15 minutes delayed.